FARESTON® (ТOREMIFENE) DOSE OPTIMIZATION IN TREATMENT OF PATIENTS WITH LOCAL FORMS OF DISHORMONAL MAMMARY DYSPLASIAS DEPENDING ON THE RECEPTOR STATUS

Shpon’ka I.S., Bondareva V.A.

The paper analyses the efficacy of the application of different doses of Fareston depending on the receptor status (ER, PR) of the breast tissue in patients with local forms of dishormonal mammary dysplasia.